Pharmaceutical News

RSS
Pfizer wins day in court over Celebrex

Pfizer wins day in court over Celebrex

New non-addictive pain-killers

New non-addictive pain-killers

Spectral announces license agreement with Bio-Rad Pasteur S.A.

Spectral announces license agreement with Bio-Rad Pasteur S.A.

Schering-Plough acquires Organon BioSciences

Schering-Plough acquires Organon BioSciences

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

Anti-cancer drug made from soil bacteria

Anti-cancer drug made from soil bacteria

Pfizer to acquire Coley Pharmaceutical Group

Pfizer to acquire Coley Pharmaceutical Group

Age Intervention Eyelash products seized by U.S. Marshals

Age Intervention Eyelash products seized by U.S. Marshals

Eyelash growth product can damage vision

Eyelash growth product can damage vision

New proposed monographs for dietary supplements

New proposed monographs for dietary supplements

FDA to improve advisory committee processes

FDA to improve advisory committee processes

Rising drug expenditures for ADHD

Rising drug expenditures for ADHD

Drug to treat children with bipolar disorder gets priority review

Drug to treat children with bipolar disorder gets priority review

Top selling diabetes drug to carry back box warning

Top selling diabetes drug to carry back box warning

GlaxoSmithKline implements changes to the US product label for Avandia

GlaxoSmithKline implements changes to the US product label for Avandia

Petition aims to stem the flood of dangerous drugs reaching Americans

Petition aims to stem the flood of dangerous drugs reaching Americans

FDA adds warning for heart attacks to type 2 diabetes drug Avandia

FDA adds warning for heart attacks to type 2 diabetes drug Avandia

Sanofi Pasteur and Acambis to bring West Nile vaccine to market

Sanofi Pasteur and Acambis to bring West Nile vaccine to market

Pfizer and Nektar resolve outstanding Exubera contractual issues

Pfizer and Nektar resolve outstanding Exubera contractual issues

Nanoviricide drug candidate effectiveness confirmed against rabies and influenzas

Nanoviricide drug candidate effectiveness confirmed against rabies and influenzas

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.